Spotlight on CTCs
Circulating tumor cells can be a prognostic factor, predictive for therapy response and allow better monitoring of treatments. But how can we analyze CTCs when they are present in low numbers and background leucocytes are co-isolated from blood samples?
A webinar on how to gain insights from CTCs (Constanze Kindler from QIAGEN) gives the answers.
Download our poster and guides to gain further insights into CTCs.
Download our guide: the power of a splice – accurate detection of AR-V7 is essential to gain new insights into prostate cancer.
Curious about what CTCs could tell you? Download the brochure and learn about why you should care about circulating tumor cells.